I/VC  WRF Capital

http://www.wrfseattle.org





     Office Locations:

2815 Eastlake Avenue E, Suite 300
Seattle, WA 98102
Phone: 206-336-5600
Fax: 206-336-5615

 

Stages:

  • Seed


 

Industries:

  • Energy & Clean Tech
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Retail & Restaurant
  • Software & Internet

  •  

    Description:

    Washington Research Foundation (WRF) was founded in 1981 to help Washington State research institutions capture value from emerging technologies through intellectual property management and start-up investment activities. WRF is an independent private foundation whose operational revenue comes from retained funds from licensing and investing activities. WRF Capital manages Washington Research Foundation's (WRF) seed venture fund by creating and investing primarily in technology-based start-up companies that have strong ties to the University of Washington and other non-profit research institutions in Washington State. WRF Capital invests in two types of companies: (1) WRF founded companies in which WRF Capital and an entrepreneur create a business concept and start a company and (2) Non-WRF founded companies in which WRF Capital invests in a company opportunity presented by an entrepreneur. In both cases, WRF Capital actively seeks co-investors, investing up to $2 million in the firm's portfolio companies with proceeds from investments used to make financial gifts to Washington State research institutions. WRF invests only in companies located in Washington State with ties to not-for-profit research insitutions. The industry focus includes IT, Life Sciences, and Physical Sciences. In addition to providing seed capital through WRF Capital, the WRF leases office space to technology-based start-ups through the WRF Venture Center. The WRF Venture Center offers entrepreneurs short-term, flexible office facilities and business support in a desirable location on Lake Union, midway between the University District and downtown Seattle.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    John Reagh Managing Director
    Loretta Little Managing Director
    Luciana Simoncini PhD Director
    Ronald S. Howell President and CEO
    Thong Q. Le Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/20/2017


      Arzeda


      WA


      $12,000,000


      Series A


      04/27/2017


      WiBotic


      WA


      $2,500,000


      Seed


     

    Portfolio companies include:


      Accelerator Corp.
        web link


      Accium BioSciences
        web link


      Alder BioPharmaceuticals
        web link


      Amnis
        web link


      AnswerDash
        web link


      ApoGen Biotechnologies
        web link


      Arzeda
        web link


      Cardeas Pharma
        web link


      EKOS
        web link


      EnerG2
        web link


      Farecast
        web link


      FlexMinder
        web link


      GlobeImmune
        web link


      Groove Biopharma Corp.
        web link


      Hyperion Therapeutics
        web link


      Lumera
        web link


      MicroGREEN Polymers
        web link


      Mirador Medical
        web link


      MobiSante
        web link


      Modumetal
        web link


      nLight Photonics
        web link


      OncoFactor
        web link


      Qazzow
        web link


      Resolve Therapeutics
        web link


      Sigby
        web link


      Targeted Growth
        web link


      TeachTown
        web link


      TraceDetect
        web link


      Uptake
        web link


      UptakeMedical
        web link


      WiBotic
        web link


     

    Recent News:


      There is no recent news for WRF Capital.